TY - JOUR A1 - Tetali, Sarada D. A1 - Jankowski, Vera A1 - Luetzow, Karola A1 - Kratz, Karl A1 - Lendlein, Andreas A1 - Jankowski, Joachim T1 - Adsorption capacity of poly(ether imide) microparticles to uremic toxins JF - Clinical hemorheology and microcirculation : blood flow and vessels N2 - Uremia is a phenomenon caused by retention of uremic toxins in the plasma due to functional impairment of kidneys in the elimination of urinary waste products. Uremia is presently treated by dialysis techniques like hemofiltration, dialysis or hemodiafiltration. However, these techniques in use are more favorable towards removing hydrophilic than hydrophobic uremic toxins. Hydrophobic uremic toxins, such as hydroxy hipuric acid (OH-HPA), phenylacetic acid (PAA), indoxyl sulfate (IDS) and p-cresylsulfate (pCRS), contribute substantially to the progression of chronic kidney disease (CKD) and cardiovascular disease. Therefore, objective of the present study is to test adsorption capacity of highly porous microparticles prepared from poly(ether imide) (PEI) as an alternative technique for the removal of uremic toxins. Two types of nanoporous, spherically shaped microparticles were prepared from PEI by a spraying/coagulation process. PEI particles were packed into a preparative HPLC column to which a mixture of the four types of uremic toxins was injected and eluted with ethanol. Eluted toxins were quantified by analytical HPLC. PEI particles were able to adsorb all four toxins, with the highest affinity for PAA and pCR. IDS and OH-HPA showed a partially non-reversible binding. In summary, PEI particles are interesting candidates to be explored for future application in CKD. KW - Adsorption of uremic toxins KW - chronic kidney disease (CKD) KW - hydrophobic uremic toxins KW - poly(ether imide) KW - microparticles KW - uremia Y1 - 2016 U6 - https://doi.org/10.3233/CH-152026 SN - 1386-0291 SN - 1875-8622 VL - 61 SP - 657 EP - 665 PB - IOS Press CY - Amsterdam ER - TY - JOUR A1 - Heuchel, Matthias A1 - Gerber, David A1 - Kratz, Karl A1 - Lendlein, Andreas T1 - Morphological analysis of differently sized highly porous poly(ether imide) microparticles by mercury porosimetry JF - Polymers for advanced technologies N2 - Highly porous poly(ether imide) (PEI) microparticles prepared by a spraying/coagulation process are discussed as candidate adsorber materials for apheresis applications, i.e. removal of uremic toxins from the blood of renal failure patients. PEI particles obtained by the aforementioned procedure can have a broad size distribution with particle diameters ranging from 20 to 800 mu m. In order to further estimate the adsorption behavior of PEI microparticles packed in application relevant apheresis modules, a quantitative information about the relation between particle size and pore morphology is required. In this study, we explored whether the intraparticle porosity of PEI microparticles varies with altering the diameter of the particulate adsorbers. By an analytical wet sieving procedure, the obtained PEI microparticles were separated into five size fractions, which were analyzed by mercury intrusion porosimetry, nitrogen adsorption, and scanning electron microscopy. Mercury intrusion porosimetry revealed for all size fractions high porosity values in the range from 78% to 84% with pore diameters in the range from 10 to 1000nm. A bimodal pore size distribution was found having a first peak at around 100nm, while a second pronounced peak maximum was found at higher pore sizes that increased with raising particle diameter from 300nm for the smallest particle size fraction (50-100 mu m) to 700nm for particles with a diameter of 200 to 250 mu m. Based on these findings, it can be assumed that the main PEI particle size fraction (200-250 mu m) should exhibit the highest adsorption capacity in an apheresis module. Copyright (c) 2016 John Wiley & Sons, Ltd. KW - porous microparticles KW - poly(ether imide) KW - mercury intrusion porosimetry KW - adsorber materials Y1 - 2017 U6 - https://doi.org/10.1002/pat.3973 SN - 1042-7147 SN - 1099-1581 VL - 28 SP - 1269 EP - 1277 PB - Wiley CY - Hoboken ER - TY - JOUR A1 - Haase, Tobias A1 - Krost, Annalena A1 - Sauter, Tilman A1 - Kratz, Karl A1 - Peter, Jan A1 - Kamann, Stefanie A1 - Jung, Friedrich A1 - Lendlein, Andreas A1 - Zohlnhöfer, Dietlind A1 - Rüder, Constantin T1 - In vivo biocompatibility assessment of poly (ether imide) electrospun scaffolds JF - Journal of Tissue Engineering and Regenerative Medicine N2 - Poly(ether imide) (PEI), which can be chemically functionalized with biologically active ligands, has emerged as a potential biomaterial for medical implants. Electrospun PEI scaffolds have shown advantageous properties, such as enhanced endothelial cell adherence, proliferation and low platelet adhesion in in vitro experiments. In this study, the in vivo behaviour of electrospun PEI scaffolds and PEI films was examined in a murine subcutaneous implantation model. Electrospun PEI scaffolds and films were surgically implanted subcutaneously in the dorsae of mice. The surrounding subcutaneous tissue response was examined via histopathological examination at 7 and 28days after implantation. No serious adverse events were observed for both types of PEI implants. The presence of macrophages or foreign body giant cells in the vicinity of the implants and the formation of a fibrous capsule indicated a normal foreign body reaction towards PEI films and scaffolds. Capsule thickness and inflammatory infiltration cells significantly decreased for PEI scaffolds during days 7-28 while remaining unchanged for PEI films. The infiltration of cells into the implant was observed for PEI scaffolds 7days after implantation and remained stable until 28days of implantation. Additionally some, but not all, PEI scaffold implants induced the formation of functional blood vessels in the vicinity of the implants. Conclusively, this study demonstrates the in vivo biocompatibility of PEI implants, with favourable properties of electrospun PEI scaffolds regarding tissue integration and wound healing. KW - poly(ether imide) KW - in vivo study KW - electrospun scaffold KW - capsule formation KW - foreign body giant cells KW - vascularization Y1 - 2017 U6 - https://doi.org/10.1002/term.2002 SN - 1932-6254 SN - 1932-7005 VL - 11 IS - 4 SP - 1034 EP - 1044 PB - Wiley CY - Hoboken ER -